Cadila Healthcare has informed that it has enclosed a copy of press release dated October 17, 2020 titled ‘Zydus Cadila receives Final Approval from USFDA for Ursodiol Capsules and Tentative Approval for Linagliptin and Metformin Hydrochloride Tablets’.
The above information is a part of company’s filings submitted to BSE.